Quinton C. Oswald of Vero Beach Florida is the CEO of Notal Vision, a cloud-based telemedicine company driven by AI tools. Most recently, he served as CEO of Neurotech and prior to that, CEO of SARcode Bioscience, where he was instrumental in the clinical development of lifitegrast ophthalmic solution 5% (Xiidra™) for the treatment of dry eye disease, and its subsequent sale to Shire, PLC.